Neurocrine Biosciences (NBIX) Receivables - Other (2019 - 2021)
Historic Receivables - Other for Neurocrine Biosciences (NBIX) over the last 3 years, with Q3 2021 value amounting to $2.8 million.
- Neurocrine Biosciences' Receivables - Other fell 2000.0% to $2.8 million in Q3 2021 from the same period last year, while for Sep 2021 it was $2.8 million, marking a year-over-year decrease of 2000.0%. This contributed to the annual value of $3.7 million for FY2020, which is N/A changed from last year.
- Per Neurocrine Biosciences' latest filing, its Receivables - Other stood at $2.8 million for Q3 2021, which was down 2000.0% from $2.7 million recorded in Q2 2021.
- Neurocrine Biosciences' Receivables - Other's 5-year high stood at $4.7 million during Q1 2020, with a 5-year trough of $463000.0 in Q3 2019.
- Its 3-year average for Receivables - Other is $3.1 million, with a median of $3.4 million in 2020.
- In the last 5 years, Neurocrine Biosciences' Receivables - Other surged by 65593.95% in 2020 and then crashed by 3191.49% in 2021.
- Over the past 3 years, Neurocrine Biosciences' Receivables - Other (Quarter) stood at $463000.0 in 2019, then skyrocketed by 699.14% to $3.7 million in 2020, then fell by 24.32% to $2.8 million in 2021.
- Its last three reported values are $2.8 million in Q3 2021, $2.7 million for Q2 2021, and $3.2 million during Q1 2021.